Introduction
- Benzodiazepines are used for numerous acute states in the emergency department, especially
- IV access is often not available for patients with seizures or agitation and alternative routes must be
- This handout will focus on the pharmacokinetics of the two most utilized benzodiazepines in the
seizures and agitation
considered; the drug of choice may change depending on the route of administration
emergency department, lorazepam and midazolam
Clinical Detail
- 5-2 mg
- 5-2mg
- 5 -2mg
- 5-2mg
- 2mg/kg
- 2mg/kg; max
- 1mg/kg
Lorazepam
Midazolam
Administration
IV
IM
IV
IM
IN
Dose
Sedation:
Seizure: 4mg
Sedation:
Seizure:
(not preferred)
Sedation:
Seizure:
(not preferred)
Sedation: 5mg
Seizure:10mg or
10mg
Sedation:
Seizure: 0.2mg/kg;
max 10mg
Onset
2-10 min
(longer for
anticonvulsant)
20-30 min
3-5 min
15 min
10 min
Duration
3 – 6 hours for
seizures, up to 8
hours for sedation
Evidence
Author,
year
Design/ sample
size
Intervention & Comparison
Outcome
Nobay
2004
Prospective,
double-blind,
randomized
N=95
IM midazolam vs. IM haloperidol vs.
IM lorazepam for agitation
Mean time to sedation (min)
Lorazepam: 32.3 (+/-20)
Midazolam: 18.3 (+/-14)
Haloperidol: 28.3 (+/-25)
*lorazepam dropped from study due to
significantly longer time to sedation and
awakening
Silbergleit
2012
Prospective,
double-blind,
randomized,
non-inferiority
N= 893
IM midazolam versus IV lorazepam
for seizure
Seizures absent at time of arrival to ED
IM midazolam: 73.4%
IV lorazepam: 63.4%
Statistically significant for non-inferiority
Faster time to drug administration of IM
midazolam was offset by the faster onset of
IV lorazepam
Haut
2016
Systematic
Review
N=75 studies
Conclusions
- The initial agent used does not have to be the definitive agent for treatment. Utilizing alternative
- A lack of literature directly comparing all routes of administration for all benzodiazepines should not
routes in order to obtain IV access in agitation/convulsing patients is often the safest for both the
patient and staff members. It may also allow therapy to be initiated faster than waiting to obtain
IV access.
limit utilization. Important differences exist in pharmacokinetics of each drug and route of
administration that may be beneficial for specific populations and disease states.
References
Lorazepam. Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, February 24.
http://www.micromedexsolutions.com/
Midazolam. Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, February 24.
http://www.micromedexsolutions.com/
Lorazepam. Lexicomp [online database].Hudson, OH. Woltes Kluwer Clinical Drug Information, Inc. Accessed 2020, February 24. http://www.online.lexi.com
Midazolam. Lexicomp [online database].Hudson, OH. Woltes Kluwer Clinical Drug Information, Inc. Accessed 2020, February 24. http://www.online.lexi.com
Nobay, et al. Acad Emerg Med. 2004;11(7):744-49.
Haut, et al. Epilepsy & Behavior. 2016;63:109-17.
Silbergleit, et al. NEJM. 2012;366(7):591-600.
Owusu, et al. Epilepsy & Behavior. 2019;98:161-67.
A short weekly clinical Pearl for acute care pharmacists. We tag this signup for Pharmacy Friday Pearls in Mailchimp and mirror it to Brevo List 6 when the subscriber record syncs.
Get the Friday Pearl email
Get a short weekly clinical Pearl for acute care pharmacists. No spam.
Free forever. Unsubscribe anytime. No spam.